Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas (LAR)

This study has been terminated.
(unable to identify a third subject)
Information provided by:
University of Pennsylvania Identifier:
First received: June 23, 2009
Last updated: November 14, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2011
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)